MJM Technology Group’s Post

At Saints Sages Surgical, innovation is in our DNA. We don’t just follow trends or replicate what's already out there. We’re trailblazers, creating breakthrough solutions like our SA10 and SA100 systems—both globally unique and designed to set new standards in surgical energy technology. But we’re not stopping here. The future holds even more surprising and revolutionary products, designed to reshape the surgical landscape. We are continuously pushing the boundaries, driven by the belief that innovation is the key to improving patient outcomes and empowering surgeons with cutting-edge tools. We invite surgeons and business partners to join us on this exciting journey. By combining your expertise with our powerful R&D capabilities, together we can develop game-changing solutions that truly benefit patients and transform surgical care. Stay tuned—because at Saints Sages, innovation never rests. #Innovation #SurgicalExcellence #CuttingEdge #Partnership #SaintsSagesSurgical #SA10 #SA100

Exciting Innovations in Interspinous Medical Devices 🏥 Groundbreaking advancements in interspinous medical devices are reshaping spinal treatment, offering improved efficacy and enhanced patient outcomes. Key trends include: - Minimally Invasive Solutions for quicker recovery and reduced complications. - Personalized Treatment Approaches enhancing effectiveness through precision medicine. - Technological Integration with smart sensors for real-time feedback. - Patient-Centric Design focusing on comfort, mobility, stability, and support. These trends are streamlining healthcare delivery with cost-effective solutions and better outcomes, improving patient quality of life. With a commitment to pushing boundaries and driving innovation, KIC Ventures is playing a pivotal role in shaping the future of spinal treatment. By investing in cutting-edge technologies and supporting groundbreaking research, KIC Ventures is enabling the development of next-generation interspinous devices that are revolutionizing patient care. As we embrace these latest trends in interspinous medical devices, it's inspiring to see how KIC Ventures continues to lead by example, paving the way for impactful advancements that improve patient outcomes and enhance healthcare delivery. Together, let's navigate these innovations and usher in a new era of spinal healthcare excellence! 💡💪 Visit our website today for more information on our minimiallly invasive solutions applying the LESS technique at NANISX.com. #KICVentures #HealthcareInnovations #SpinalTreatmentok #MedicalDevices

🔔 Radiotherapy can be daunting, with patients often confronted by large, complex machines. But what if these devices could be designed to not only deliver precise treatment but also ease anxiety⁉️ 📖 More information about 'We focus on people—advanced product design in radiotherapy' by Annette Schindler you may find in the latest issue of the EFOMP's #Summer #EMPNews, the LAP experts dive into the development of the LUNA 3D, a cutting-edge example of product design that prioritizes the needs of both patients and healthcare providers. Learn how thoughtful design can create a calming atmosphere in treatment rooms, making a difference in the patient experience 👉 #EFOMP #company #member LAP Laser #article on p.26 🔗 https://lnkd.in/dxh8mwX 📧 If you would like to receive each issue of EMP News as soon as it is published you can subscribe to our mailing list 👇 🔗 https://lnkd.in/duGAiXkY

SpectraWAVE Secures $50M to Improve Treatment for Coronary Artery Disease A medical imaging company providing technology solutions to improve treatment for people with coronary artery disease, SpectraWAVE, Inc., has secured $50 million in Series B funding round to support commercial expansion and the addition of new products. Co-founded in 2017 by Guillermo Tearney and Gregg Stone, SpectraWAVE has developed an intravascular imaging technology, HyperVue™ Imaging System, which leverages photonics to improve the outcomes for coronary artery disease patients. The round was spearheaded by Johnson & Johnson Innovation – Johnson & Johnson Innovation JJDC Inc., with notable contributions from Lumira Ventures, S3 Ventures, Deerfield Management, SV Health Investors, Heartwork Human Capital, LLC, and NOVAVENTURE, LLC, alongside other undisclosed angel investors. Read more: https://lnkd.in/gRd9gGkr #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

🔔 𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐟𝐮𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐟𝐫𝐨𝐦 𝐄𝐅𝐎𝐌𝐏! "We Focus on People—Advanced Product Design in Radiotherapy” highlights how our 𝐋𝐔𝐍𝐀 𝟑𝐃 improves patient comfort and treatment efficiency. 𝐀𝐫𝐭𝐢𝐜𝐥𝐞 𝐨𝐧 𝐩.𝟐𝟔 🔗 https://lnkd.in/dsFQMj76

💡 From Disc problems to Disc solutions 🚀 We're excited to announce that Discure Technologies has secured a $16M Series A round, led by Supernova Invest, BOLD Capital Partners, and Sanara Capital! This funding will accelerate clinical trials of their innovative bioelectronic device that targets degenerative disc disease (DDD), aiming not just to manage symptoms but to reverse the root cause of disc degeneration! 🦾 At Supernova Invest, we believe in bold technologies with a massive impact. As Pascal-andré Chenal, our Investment Director, says: "Discure is the only medical device company that tackles the root cause of disc disease. Their early-stage treatment will help avoid invasive surgeries, and we are thrilled to support their journey!" 🌍 With back pain affecting millions worldwide, Discure Technologies is changing the game for patients and healthcare providers by offering a less invasive and more effective solution. We are proud to be part of this revolutionary step towards better spinal health! #DeepTech #HealthTech #Innovation #Investment #MedicalTechnology #SupernovaInvest

Did You Know Axiom is not just a provider? 🌟 Axiom Neuromonitoring is not just a provider of top-tier neuromonitoring services; we have also become an official distributor of neuromonitoring devices by partnering with Dr. Langer, a manufacturer from Germany. 💡 Discover why our dual role in services and distribution is a natural fit: 🔹 Expertise in Action: Our team’s hands-on experience in surgeries allows us to understand the precise needs and challenges faced by surgical teams. This insight enables us to provide the most effective and reliable neuromonitoring solutions. 🔹 Cutting-Edge Technology: By partnering with Dr. Langer, we bring the latest neuromonitoring innovations directly to you. Our devices are designed to deliver real-time data and enhance surgical outcomes. 🔹 Comprehensive Support: We offer both services and devices, ensuring a seamless integration and comprehensive support for your neuromonitoring needs. Discover the synergy between our expert services and the devices we distribute. Trust Axiom Neuromonitoring for all your neuromonitoring solutions. Learn more: https://lnkd.in/evjBNmS5 www.axiomdevices.co.uk #AxIOMNeuromonitoring #AxIOMDevices #PatientSafty #DidYouKnow #Neuromonitoring #MedicalDevices #LangerMedical #HealthcareInnovation

Funding remains tight across the healthcare space. At Alruna, you encouraged our investments to focus on delivering short term goals while executing mindset of driving $1.75 of value from every $1 received. With the speed of LLMs and Ai modeling provides some support; but, the real progress comes from the leaders executing each day. 2025 should show new inflows of capital that has been sitting on the sidelines moving into investments that have delivered key milestones and have a clear FDA and reimbursement pathway. Q4/24 will be the set up. It will be exciting to participate in investing in our current investments while exploring new opportunities. MedTech Innovator #tcala #investing #patientoutcomes #execution #mindset LSI #medtech #investing #angelinvesting #venturecapital #smartinvesting #AI #medicaldevives

𝘽𝙍𝙀𝘼𝙆𝙄𝙉𝙂: 𝙀𝙣𝙙𝙤𝙨𝙘𝙤𝙥𝙮 𝘿𝙚𝙫𝙞𝙘𝙚𝙨 𝙈𝙖𝙧𝙠𝙚𝙩 𝙋𝙤𝙞𝙨𝙚𝙙 𝙛𝙤𝙧 𝙍𝙚𝙢𝙖𝙧𝙠𝙖𝙗𝙡𝙚 𝙂𝙧𝙤𝙬𝙩𝙝 💡: 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙫𝙚 𝙏𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙞𝙚𝙨 𝙖𝙣𝙙 𝙍𝙞𝙨𝙞𝙣𝙜 𝘿𝙚𝙢𝙖𝙣𝙙 𝘿𝙧𝙞𝙫𝙚 𝙈𝙖𝙧𝙠𝙚𝙩 #Endoscopy devices market is experiencing significant growth due to advancements in technology and increasing demand for minimally invasive procedures. 🌟 Innovations such as high-definition imaging and flexible endoscopes are driving market expansion, catering to diverse #medical needs. 🏥 With #rising awareness and acceptance of endoscopic procedures, the market is poised for continued growth in the foreseeable future. 💼🔬 𝙁𝙤𝙧 𝙈𝙤𝙧𝙚 𝙄𝙣𝙛𝙤: https://bit.ly/486tna6 Key Players: Boston Scientific,Cook Medical, CONMED Corporation, Richard Wolf GmbH,Johnson & Johnson,FUJIFILM Holdings Corporation, Medtronic Plc,Olympus Corporation. #EndoscopyDevices #MedicalInnovation #MinimallyInvasive #HealthcareTech #InnovativeDevices #EndoscopicProcedures #MedicalTechnology #MarketGrowth #HealthcareTrends 🌐🔬

NeuroBell, a pioneering medical technology company, has successfully secured €2.1 million in funding for its groundbreaking technology designed to detect and monitor neonatal seizures. This significant investment will enable NeuroBell to further develop and refine their innovative solution, ultimately improving the care and outcomes for newborns at risk of seizures. 🚀💼💉 NeuroBell's focus on addressing the critical issue of neonatal seizures with their state-of-the-art technology is a clear demonstration of the immense potential that lies at the intersection of medicine and innovation. It is inspiring to see companies like NeuroBell making significant strides in leveraging technology to make a meaningful difference in the lives of vulnerable patients. 🏥💡🌍 The successful funding round for NeuroBell is not only a testament to the potential of their neonatal seizure tech, but also a reminder of the importance of investing in pioneering solutions that have the power to transform healthcare for the better. #HealthTech #Innovation #NeonatalCare